Albany Molecular Profile

21.74

USD

0.00

0.00%

Trading Day

21.74

Valuation Profit Patterns

Albany Molecular Stories on April 23, 2018

Selected Albany Molecular Research Income Statement Over Time

Add

Earning Before Interest and Taxes EBIT Interest Expense Net Income

Key Fundamentals

Return On Asset	0.36 %
Profit Margin	(8.78) %
Operating Margin	0.87 %

More Fundamentals

Albany Molecular Against Markets

Nasdaq	1.30 %	0%	100.0%	Nasdaq Profile Nasdaq Dashboard Nasdaq Technical analysis Backtest Nasdaq
SP 500	0.87 %	0%	66.0%	SP 500 Profile SP 500 Dashboard SP 500 Technical analysis Backtest SP 500
DOW	0.83 %	0%	63.0%	DOW Profile DOW Dashboard DOW Technical analysis Backtest DOW
Russel	0.62 %	0%	47.0%	Russell 2000 Profile Russell 2000 Dashboard Russell 2000 Technical analysis Backtest Russell 2000
NYSE	0.51 %	0%	39.0%	NYSE Profile NYSE Dashboard NYSE Technical analysis Backtest NYSE
AMRI	0.00 %	0%	0%	Albany Molecular Profile Albany Molecular Dashboard Albany Molecular Fundamentals Trends

Compare to Competition

Compare Correlations

Diagnostics

Albany Molecular Research, Inc., a contract research and manufacturing company, offer integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. more

Business Services

Fama & French Classification

Name

Albany Molecular Research

CEO and President and Director

William Marth View All

Analyst Consensus

Buy 3 Opinions

Macroaxis Advice

Not RatedUnknown Value

Instrument

USA Stock View All

Region

North America

Location

NEW YORK, U.S.A

Business Address

26 Corporate Circle, Albany, NY 12203, United States

Exchange

NASDAQ

CIK Number

01065087.0

CUSIP

012423109

Industry

Website

Contact Number

Currency

USD - US Dollar

Other Suggestions

View Currently Related Equities

Genpact Limited NetSuite Visa Zillow Air Lease BlackLine Broadridge Financial Bazaarvoice CA Electronic Arts American Airlines Alcoa Apple Best Buy Citigroup

Risk & Return

Correlation

Diversify with Albany Molecular Research

Build Optimal Portfolios

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Albany Molecular Research to your portfolio

Fix your portfolios for free

Directors

Albany Molecular Corporate Directors

Arthur Roth Independent Director
Gerardo Gutierrez Director
Anthony Maddaluna Director, MBA

Check also Trending Equities. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.